Estimated Burden of Stroke in China in 2020

Abstract

ImportanceStroke is the leading cause of death in China. However, recent data about the up-to-date stroke burden in China are limited.ObjectiveTo investigate the urban-rural disparity of stroke burden in the Chinese adult population, including prevalence, incidence, and mortality rate, and disparities between urban and rural populations.Design, Setting, and ParticipantsThis cross-sectional study was based on a nationally representative survey that included 676 394 participants aged 40 years and older. It was conducted from July 2020 to December 2020 in 31 provinces in mainland China.Main Outcomes and MeasuresPrimary outcome was self-reported stroke verified by trained neurologists during a face-to-face interviews using a standardized protocol. Stroke incidence were assessed by defining first-ever strokes that occurred during 1 year preceding the survey. Strokes causing death that occurred during the 1 year preceding the survey were considered as death cases.ResultsThe study included 676 394 Chinese adults (395 122 [58.4%] females; mean [SD] age, 59.7 [11.0] years). In 2020, the weighted prevalence, incidence, and mortality rates of stroke in China were 2.6% (95% CI, 2.6%-2.6%), 505.2 (95% CI, 488.5-522.0) per 100 000 person-years, and 343.4 (95% CI, 329.6-357.2) per 100 000 person-years, respectively. It was estimated that among the Chinese population aged 40 years and older in 2020, there were 3.4 (95% CI, 3.3-3.6) million incident cases of stroke, 17.8 (95% CI, 17.5-18.0) million prevalent cases of stroke, and 2.3 (95% CI, 2.2-2.4) million deaths from stroke. Ischemic stroke constituted 15.5 (95% CI, 15.2-15.6) million (86.8%) of all incident strokes in 2020, while intracerebral hemorrhage constituted 2.1 (95% CI, 2.1-2.1) million (11.9%) and subarachnoid hemorrhage constituted 0.2 (95% CI, 0.2-0.2) million (1.3%). The prevalence of stroke was higher in urban than in rural areas (2.7% [95% CI, 2.6%-2.7%] vs 2.5% [95% CI, 2.5%-2.6%]; P = .02), but the incidence rate (485.5 [95% CI, 462.8-508.3] vs 520.8 [95% CI, 496.3-545.2] per 100 000 person-years; P < .001) and mortality rate (309.9 [95% CI, 291.7-328.1] vs 369.7 [95% CI, 349.1-390.3] per 100 000 person-years; P < .001) were lower in urban areas than in rural areas. In 2020, the leading risk factor for stroke was hypertension (OR, 3.20 [95% CI, 3.09-3.32]).Conclusions and RelevanceIn a large, nationally representative sample of adults aged 40 years or older, the estimated prevalence, incidence, and mortality rate of stroke in China in 2020 were 2.6%, 505.2 per 100 000 person-years, and 343.4 per 100 000 person-years, respectively, indicating the need for an improved stroke prevention strategy in the general Chinese population.

Factors associated with health behaviours among stroke survivors: A mixed‐methods study using COM‐B model

“…Looking ahead, the number of stroke survivors is projected to increase by 27% by the year 2047 within the European Union (Wafa et al, 2020). In the United States, stroke remains a grave concern, with 14,000 deaths attributed to it annually, accounting for approximately one out of every 20 deaths in the country (Tu et al, 2023). China faces an especially formidable challenge in the realm of stroke.…”

An investigation of the level of stigma and the factors influencing it in the rehabilitation of young and middle-aged stroke patients-a cross-sectional study

“…It is the second-leading cause of death and disability worldwide [ 4 – 6 ], with five major characteristics: high morbidity, disability, mortality, recurrence, and economic burden [ 7 ]. However, the problem of stroke is more serious and prominent in China, with a recent study showing that the overall prevalence, morbidity, and mortality of stroke among adults aged 40 years and older is estimated to be 2.6% in 2020 [ 8 ], and stroke has been classified as a major chronic noncommunicable disease in China and is the leading cause of death and disability among Chinese adults [ 7 ],Stroke has become a disaster, threatening human life, health, and quality of life [ 9 ].…”

Serum homocysteine level is an independent risk factor for 1-year stroke recurrence in patients with acute ischemic stroke and H-type hypertension: results from the Xi'an stroke registry study of China

“…Stroke is the second leading cause of mortality worldwide and the primary cause of disability and mortality in China (1)(2)(3). In 2020, ischemic stroke constituted 15.5 million (86.8%) of all incident stroke cases in the Chinese population aged ≥40 years (4). Hypertension is one of the leading risk factors for stroke (1)(2)(3)(4).…”

“…In 2020, ischemic stroke constituted 15.5 million (86.8%) of all incident stroke cases in the Chinese population aged ≥40 years (4). Hypertension is one of the leading risk factors for stroke (1)(2)(3)(4). Previous studies have revealed a closer relationship between hypertension and stroke in Asian populations, especially among the Chinese, than that in the European, American, Australian, and New Zealand populations (5)(6)(7).…”